Cat No.
CEI-0449
Description
A selective inhibitor of the cGMP-specific phosphodiesterase (PDE2) (IC50s = 0.8 and 2 μM from human and porcine myocardium, respectively, 3.5 μM in rat hepatocyte, and 5.5 μM in human platelet). Also a reversible adenosine deaminase inhibitor (IC50 = 1.2 μM in human red blood cells)
Alias
NSC 263164
Synonyms
NSC 263164
CAS No.
58337-38-5
Product_Overview
A cGMP-specific phosphodiesterase (PDE2) inhibitor
Targets
PDE2A
Chemical Name
erythro-9-(2-Hydroxy-3-nonyl)adenine; (αR,?βS)-?rel-?6-?amino-?β-?hexyl-α-methyl-9H-purine-9-ethanol, monohydrochloride
M.Wt
499.3
Purity
>95% by HPLC
Appearance
White solid
Solubility
DMSO and MEOH
Storage
-20 centigrade
Shipping Conditions
Gel pack
Handling
Protect from air and moisture
Usage
For Research Use Only! Not For Use in Humans.